Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation.

In conclusion, our findings support the hypothesis that immune dysregulation plays an important role in stress-induced anxiety disorders, and minocycline can be developed to be used in these diseases.
PMID: 30149196 [PubMed - as supplied by publisher]

Source: Brain Research Bulletin - August 24, 2018 Category: Neurology Authors: Haiyan L, Jiao Y, Lining H, Lifei C, Xinshang W, Xiaojuan W, Feng B Tags: Brain Res Bull Source Type: research